What is the best treatment target in axial spondyloarthritis: tumour necrosis factor &agr;, interleukin 17, or both?
Sign Up to like & getrecommendations! Published in 2017 at "Rheumatology"
DOI: 10.1093/rheumatology/kex361
Abstract: After about 15 years of experience with the TNF blockers as the only effective drugs in axial spondyloarthritis patients who fail conventional treatment, for the first time we see now that another targeted therapy, the… read more here.
Keywords: target axial; treatment; best treatment; treatment target ... See more keywords